Communiqué Presse

WHO Meeting of the Scientific and Technical Advisory Committee on Ebola Experimental Interventions

Imprimer PDF

Écrit par WHO | 14 Novembre 2014

13 November 2014 - Place: Geneva, Switzerland - Following the emergence of Ebola virus disease (EVD) as a severe public health emergency for which no effective therapeutic or prophylactic interventions are available, the scientific community has proposed numerous experimental interventions, including: vaccines; convalescent blood and plasma; and medicines. None of these interventions have...

Lire la suite... Ajouter un commentaire

Marburg virus disease - Uganda - Disease outbreak news 13 November 2014

Imprimer PDF

Écrit par WHO | 14 Novembre 2014

On 11 November 2014, the Government of Uganda declared that Uganda was free of the Marburg virus. This declaration was made at the National Media Centre by the Minister of State for Primary Health Care, Hon. Sarah Achieng Opendi.

On 4 October 2014, WHO was notified by the Government of Uganda of a case of Marburg virus disease. The case was a male health professional that developed...

Lire la suite... Ajouter un commentaire

Système de veille sanitaire SOS Médecins / Bulletin national d'information du 3 au 9 novembre 2014

Imprimer PDF

Écrit par InVS | 14 Novembre 2014

Evolution de l’activité globale

L’activité globale des associations SOS Médecins est stable dans toutes les classes d’âges sauf chez les 5-14 ans pour lesquels on note une légère augmentation du nombre de visites hebdomadaires (+12 % soit +642 visites). Les effectifs (52 272 visites hebdomadaires tous âges confondus) sont proches de ceux des années 2012 et 2013 sur...

Lire la suite... Ajouter un commentaire

Courrier de l'ANSM au laboratoire Roche concernant Avastin

Imprimer PDF

Écrit par ANSM | 09 Novembre 2014

En date du 21 octobre 2014, l’Agence nationale de sécurité du médicament et des produits de santé (ANSM) a sollicité le laboratoire Roche pour que lui soient communiquées les informations dont ce laboratoire dispose sur l’utilisation d’Avastin (bevacizumab) en dehors de son Autorisation de mise sur le marché (AMM). Cette spécialité, qui bénéficie d’une AMM en...

Lire la suite... Ajouter un commentaire

Statement from the Travel and Transport Task Force on Ebola virus disease outbreak in West Africa

Imprimer PDF

Écrit par WHO | 09 Novembre 2014

WHO statement  7 November 2014 - Leading international organizations and associations from the transport, trade and tourism sector stand firmly with the World Health Organization (WHO) against general bans on travel and trade, as well as restrictions that include general quarantine of travellers from Ebola-affected countries.

The Travel and Transport Task Force*, established in August 2014...

Lire la suite... Ajouter un commentaire

New WHO “Safe and Dignified Burial” Protocol Key to Reducing Ebola Transmission

Imprimer PDF

Écrit par WHO | 09 Novembre 2014

7 November 2014 ¦ GENEVA:  A new WHO protocol for safe and dignified burial of people who die from Ebola virus disease emphasizes inclusion of family members and encouraging religious rites as an essential part of safe burials. 

“At least 20% of new Ebola infections occur during burials of Ebola deceased patients. By building trust and respect between burial teams, bereaved...

Lire la suite... Ajouter un commentaire

WHO welcomes strong commitment from Australia to beating Ebola

Imprimer PDF

Écrit par WHO | 09 Novembre 2014

7 November 2014 ¦ GENEVA : The World Health Organization welcomes the Government of Australia’s commitment to providing health professionals and more funding to boost the fight against Ebola virus disease.

Australia joins a growing band of countries now providing health care workers as well as other desperately needed resources-funding, medical equipment and supplies-to boost efforts to...

Lire la suite... Ajouter un commentaire

WHO welcomes approval of second Ebola vaccine trial in Switzerland

Imprimer PDF

Écrit par WHO | 09 Novembre 2014

The World Health Organization (WHO) welcomes approval by Swissmedic, the Swiss regulatory authority for therapeutic products, for a second Swiss trial with an experimental Ebola vaccine.  The trial will be led by the University Hospitals of Geneva (HUG).  If judged safe, larger scale trials will be taken to African countries as early as January 2015.

Approval means that the vaccine...

Lire la suite... Ajouter un commentaire

Plus d'articles...

Information

Annuaires

Vitrines Sociétés

Voir toutes les vitrines